- Trump’s Executive Order on Drug Prices Might Be More in Favour of Drug Companies
- The Government Created This Zika Vaccine. Why Should Big Pharma Reap the Profits?
- In Thailand, patient activism is crucial to expanding treatment
- The Trump Executive Order on drug prices: not what was promised nor needed, and contrary to US self interest
- June 2017 Alert: Pressure on countries hiked by US on IP
Category Archives: Drug prices
The order will likely be a far cry from the president’s previous remarks about the pharmaceutical industry. Emily Kopp has a big scoop for Kaiser Health News. She has obtained a six-page document outlining the draft provisions or objectives of a proposed presidential executive … Continue reading
Lawmakers are concerned that giving a drug company a monopoly on the promising vaccine could make it unaffordable.
The government’s premier policy-formulating agency recently recommended measures to deregulate the pharmaceutical sector and make essential medicines more expensive. New Delhi: Even as the prime minister repeatedly expresses his commitment to providing affordable medicines in the country, it appears that the NITI Aayog … Continue reading
In January 2016, KEI and the Union for Affordable Cancer Treatment petitioned the US the Department of Health and Human Services or the National Institutes of Health to use the federal government rights in the patents on the prostate cancer … Continue reading
Pharma Companies Should Sell Medicines Under Generic Names! Generic Prescription by Doctors is NOT Enough
Press Release: April 26, 2017 All India Drug Action Network Demands Substantive Measures The proposal, as announced by the Prime Minister, to make generic prescription writing mandatory for doctors, would be a useless counterproductive step as a standalone measure. This … Continue reading
Source: www.franken.senate.gov A bill on drug prices has been introduced in US Congress to bring down prescription drug prices. The Improving Access to Affordable Prescription Drugs Act aims to ensure that drug companies put patients before profits and bring relief to families … Continue reading
Novartis has threatened Colombia with international investment arbitration to avoid the issuance of a compulsory license.* The Swiss pharma giant is also turning to Colombian courts in an attempt to kill the price reduction imposed by the authorities over its … Continue reading